Takaki, Shintaro

Publishing since 1988 (Dinosaur)

Has published 75 publications in 23 years

Number of publications published per year by Takaki, Shintaro. (Source : PubMed)

Distribution of publications types for Takaki, Shintaro. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Katamura Y, Aikata H, Kimura Y, Kawaoka T, Takaki S, Waki K, Hiramatsu A, Kawakami Y, Takahashi S, Ishikawa M, Hieda M, Kakizawa H, Chayama K. Intra-arterial 5-fluorouracil/interferon combination therapy for hepatocellular carcinoma with portal vein tumor thrombosis and extrahepatic metastases.  J. Gastroenterol. Hepatol.  2010  
•  Waki K, Aikata H, Katamura Y, Kawaoka T, Takaki S, Hiramatsu A, Takahashi S, Toyota N, Ito K, Chayama K. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: Results and prognostic factors on long-term follow up.  J. Gastroenterol. Hepatol.  2010  
•  Takizawa H, Nishimura S, Takayama N, Oda A, Nishikii H, Morita Y, Kakinuma S, Yamazaki S, Okamura S, Tamura N, Goto S, Sawaguchi A, Manabe I, Takatsu K, Nakauchi H, Takaki S, Eto K. Lnk regulates integrin alphaIIbbeta3 outside-in signaling in mouse platelets, leading to stabilization of thrombus development in vivo.  J. Clin. Invest.  2010;120;1  
•  Tsumura T, Takaki S, Aikata H, Kimura Y, Katamura Y, Azakami T, Kawaoka T, Tsuge M, Sanetou H, Waki K, Hiramatsu A, Imamura M, Kawakami Y, Takahashi S, Arihiro K, Chayama K. [Case of double cancer of the liver, cholangiocarcinoma and hepatocellular carcinoma detected in a patient with hepatitis C 13 years after diminution of HCV-RNA by interferon treatment]  Nippon Shokakibyo Gakkai Zasshi  2009;106;5  
•  Mori N, Imamura M, Kawakami Y, Saneto H, Kawaoka T, Takaki S, Aikata H, Takahashi S, Chayama K. Randomized trial of high-dose interferon-alpha-2b combined with ribavirin in patients with chronic hepatitis C: Correlation between amino acid substitutions in the core/NS5A region and virological response to interferon therapy.  J. Med. Virol.  2009;81;4  
•  Katamura Y, Aikata H, Kimura Y, Azakami T, Kawaoka T, Takaki S, Waki K, Hiramatsu A, Kawakami Y, Takahashi S, Chayama K. Successful treatment of pulmonary metastases associated with advanced hepatocellular carcinoma by systemic 5-fluorouracil combined with interferon-alpha in a hemodialysis patient.  Hepatol. Res.  2009;39;4  
•  Mitsui F, Aikata H, Azakami T, Katamura Y, Kimura T, Kawaoka T, Saneto H, Takaki S, Hiraga N, Tsuge M, Waki K, Hiramatsu A, Imamura M, Kawakami Y, Takahashi S, Arihiro K, Chayama K. The first Japanese case of COACH syndrome.  Hepatol. Res.  2009;39;3  
•  Kawaoka T, Aikata H, Takaki S, Uka K, Azakami T, Saneto H, Jeong SC, Kawakami Y, Takahashi S, Toyota N, Ito K, Hirokawa Y, Chayama K. FDG positron emission tomography/computed tomography for the detection of extrahepatic metastases from hepatocellular carcinoma.  Hepatol. Res.  2009;39;2  
•  Katamura Y, Aikata H, Takaki S, Azakami T, Kawaoka T, Waki K, Hiramatsu A, Kawakami Y, Takahashi S, Kenjo M, Toyota N, Ito K, Chayama K. Intra-arterial 5-fluorouracil/interferon combination therapy for advanced hepatocellular carcinoma with or without three-dimensional conformal radiotherapy for portal vein tumor thrombosis.  J. Gastroenterol.  2009;44;5  
•  Kodama H, Aikata H, Takaki S, Takahashi S, Toyota N, Ito K, Chayama K. Evaluation of patients with esophageal varices after endoscopic injection sclerotherapy using multiplanar reconstruction MDCT images.  AJR Am J Roentgenol  2009;192;1  

[ See timeline ] [ See all publications ]